申请人:Merck & Co., Inc.
公开号:US06284755B1
公开(公告)日:2001-09-04
The present invention is directed to azepan-2-one compounds which inhibit prenyl-protein transferase, particularly farnesyl-protein transferase (Ftase), and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
本发明涉及抑制萜基-蛋白转移酶,特别是法尼基-蛋白转移酶(Ftase)以及致癌基因蛋白Ras的萜基化的环庚酮化合物。该发明还涉及含有本发明化合物的化疗组合物以及抑制萜基-蛋白转移酶和致癌基因蛋白Ras的萜基化的方法。